
Friday, April 23, 2010
Facet Solutions cites improvements in back and leg pain, raises $2.1M
By Mass High Tech staff
Facet Solutions Inc. of Hopkinton today announced results of a two-year pilot study of its treatment for lumbar stenosis, a condition where the bones of the spine compress nerves, causing back and leg pain.
The company said that its Acadia investigational device was developed as an alternative to lumbar spinal fusion. The Acadia procedure includes replacement of the degenerated posterior spinal joints with an anatomic implant that is designed to restore the natural motion, stability and balance to the lumbar spine, according to Facet. The company, which will present its study results at a conference next week, said patients in the study “experienced significant and sustained improvement in Oswestry Disability Index.” The company also said that there were no re-operations in any of the patients.
The announcement came three days after Facet filed notice with the U.S. Securities and Exchange Commission of a $2.1 million debt and warrant-based funding.
Facet is a venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet said that it has received venture capital from its partners De Novo Ventures and Spray Venture Partners, both of which have representatives on Facet’s board. The company also lists Juliet Tammenoms Bakker, founder and managing director of Longitude Capital and formerly of Pequot Ventures, as a director.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Print
Email
Print Edition Stories



